We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BMG Labtech Joins ALSSA

News   Mar 25, 2010

 
BMG Labtech Joins ALSSA
 
 
 

RELATED ARTICLES

New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

News

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

READ MORE

Cannabidiol Holds Promise as Powerful Antibiotic

News

New research has found that cannabidiol is active against Gram-positive bacteria, including those responsible for many serious infections, with potency similar to that of established antibiotics such as vancomycin or daptomycin.

READ MORE

Starving Cancer: Drug Drains Melanoma Cells of Their Energy

News

Researchers have found that two structurally similar compounds – deguelin and rotenone, naturally occurring pesticides produced by many plant species – interfered with melanoma cancer cells’ metabolism. Further testing with deguelin showed that it inhibited oxygen consumption in the cells’ mitochondria, effectively starving the cells of energy.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE